Functional effects of genetic polymorphisms in the N-acetyltransferase 1 coding and 3′ untranslated regions

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 2, 2011, Pages 77-84

  Zhu, Yuanqi ^a   States, J Christopher ^a   Wang, Yang ^a,b   Hein, David W ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acetylator genotype; Acetylator phenotype; Arylamines; Haplotypes; N acetyltransferase 1 polymorphisms

Indexed keywords

ACYLTRANSFERASE; MESSENGER RNA; N ACETYLTRANSFERASE 1; NUCLEOTIDE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BASE PAIRING; CATALYSIS; CELL STRAIN COS1; ENZYME ACTIVITY; GENE DELETION; GENETIC CODE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3' UNTRANSLATED REGIONS; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; CONGENITAL ABNORMALITIES; COS CELLS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; ISOENZYMES; LUNG; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION;

EID: 79851475806     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20763     Document Type: Article

References (48)

1. Ambrosone CB, Abrams SM, Gorlewska-Roberts K, et al. 2007. Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells. Arch Biochem Biophys 464: 169-175.
2. Bell DA, Stephens EA, Castranio T, et al. 1995. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 55: 3537-3542.
3. Bruhn C, Brockmoller J, Cascorbi I, et al. 1999. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1). Biochem Pharmacol 58: 1759-1764.
4. Carmichael SL, Shaw GM, Yang W, et al. 2006. Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake Am J Med Genet A 140: 1915-1922.
5. Chen B, Zhang WX, Cai WM., et al. 2006. The influence of various genotypes on the metabolic activity of NAT2 in a Chinese population. Eur J Clin Pharmacol 62: 355-359.
6. Chen J, Stampfer MJ, Hough HL, et al. 1998. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58: 3307-3311.
7. de Leon JH, Vatsis KP, Weber WW., et al. 2000. Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1. Mol Pharmacol 58: 288-299.
8. Doll MA, Zang Y, Moeller T, et al. 2010. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes. J Pharmacol Exp Ther 334: 540-544.
9. Erickson RP, Cao W, Acuna DK, et al. 2008. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts. Mol Reprod Dev 75: 1071-1076.
10. Fretland AJ, Doll MA, Leff MA, et al. 2001. Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. Pharmacogenetics 11: 511-520.
11. Fretland AJ, Doll MA, Zhu Y, et al. 2002. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition. Cancer Detect Prev 26: 10-14.
12. Gago-Dominguez M, Bell DA, Watson MA, et al. 2003. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24: 483-489.
13. Gemignani F, Landi S, Szeszenia-Dabrowska N, et al. 2007. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28: 1287-1293.
14. Grant DM, Hughes NC, Janezic SA, et al. 1997. Human acetyltransferase polymorphisms. Mutat Res 376: 61-70.
15. Hein DW. 1988. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37-66.
16. Hein DW. 2009. N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine. Expert Opin Drug Metab Toxicol 5: 353-366.
17. Hein DW, Leff MA, Ishibe N, et al. 2002. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT110) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study. Environ Mol Mutagen 40: 161-167.
18. Hughes NC, Janezic SA, McQueen KL, et al. 1998. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics 8: 55-66.
19. Husain A, Zhang X, Doll MA, et al. 2007. Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements. Drug Metab Dispos 35: 1649-1656.
20. Ishibe N, Sinha R, Hein DW, et al. 2002. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. Pharmacogenetics 12: 145-150.
21. Jensen LE, Hoess K, Whitehead AS, et al. 2005. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res A Clin Mol Teratol 73: 512-516.
22. Jiao L, Doll MA, Hein DW, et al. 2007. Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 16: 2379-2386.
23. Katoh T, Inatomi H, Yang M, et al. 1999. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese. Pharmacogenetics 9: 401-404.
24. Kilfoy BA, Zheng T, Lan Q, et al. 2010. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control 21: 127-133.
25. Lammer EJ, Shaw GM, Iovannisci DM, et al. 2004a. Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms. Epidemiology 15: 150-156.
26. Lammer EJ, Shaw GM, Iovannisci DM, et al. 2004b. Periconceptional multivitamin intake during early pregnancy, genetic variation of acetyl-N-transferase 1 (NAT1), and risk for orofacial clefts. Birth Defects Res A Clin Mol Teratol 70: 846-852.
27. Lee KM, Park SK, Kim SU, et al. 2003. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer Cancer Lett 196: 179-186.
28. Li D, Jiao L, Li Y, et al. 2006. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27: 103-111.
29. Lilla C, Verla-Tebit E, Risch A, et al. 2006. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15: 99-107.
30. Ma JJ, Liu CG, Li JH, et al. 2009. Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population. Clin Chim Acta 407: 30-35.
31. Millikan RC, Pittman GS, Newman B, et al. 1998. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7: 371-378.
32. Morton LM, Bernstein L, Wang SS, et al. 2007. Hair dye use, genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma. Carcinogenesis 28: 1759-1764.
33. Morton LM, Schenk M, Hein DW, et al. 2006. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma. Pharmacogenet Genomics 16: 537-545.
34. Rovito PMJr, Morse PD, Spinek K, Newman N, Jones RF, Wang CY, Haas GP. 2005. Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer. Prostate Cancer Prostatic Dis 8: 69-74.
35. Sanderson S, Salanti G, Higgins J, et al. 2007. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am J Epidemiol 166: 741-751.
36. Shi M, Wehby GL, Murray JC, et al. 2008. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today 84: 16-29.
37. Shin A, Shrubsole MJ, Rice JM, et al. 2008. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 17: 320-329.
38. Sim E, Payton M, Noble M, et al. 2000. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 9: 2435-2441.
39. Smelt VA, Upton A, Adjaye J, et al. 2000. Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos. Hum Mol Genet 9: 1101-1107.
40. Suzuki H, Morris JS, Li Y, et al. 2008. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 29: 1184-1191.
41. Taylor JA, Umbach DM, Stephens E, et al. 1998. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res 58: 3603-3610.
42. Wakefield L, Cornish V, Long H, et al. 2007. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism. Biochem Biophys Res Commun 364: 556-560.
43. Walraven JM, Trent JO, Hein DW., et al. 2008. Structure-function analyses of single nucleotide polymorphisms in human N-acetyltransferase 1. Drug Metab Rev 40: 169-184.
44. Wikman H, Thiel S, Jager B, et al. 2001. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics 11: 157-168.
45. Zang Y, Zhao S, Doll MA, et al. 2004. The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 14: 717-723.
46. Zhangwei X, Jianming X, Qiao M, et al. 2006. N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population. Clin Chim Acta 371: 85-91.
47. Zheng W, Deitz AC, Campbell DR, et al. 1999. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 233-239.
48. Zhu Y, Hein DW. 2008. Functional effects of single nucleotide polymorphisms in the coding region of human N-acetyltransferase 1. Pharmacogenomics J 8: 339-348.